UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A THE SECURITIES...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
Company Will Advance Three Clinical Stage Product Candidates Addressing Significant Unmet Needs in Dry-AMD, Spinal Cord Injury, and...
UNITED STATES...
BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that...
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that Francois...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Wa...
UNITED STATES SECURITIES AND EXCHANGE...
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-229141 ...
As filed with the Securities and Exchange Commission on January 11 , 2019 Registration No...
30M U.S. adults suffer from diabetes and 93M from obesity, with associated medical costs of over $300B annually, necessitating an urgent...
As filed with the Securities and Exchange Commission on January 4, 2019 Registration No...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.